Clinical trial
Effects of Pentazocine on Manic Symptoms
NCT00125931 · Mclean Hospital, Other · Completed
Key facts
| NCT number | NCT00125931 |
|---|---|
| Title | Effects of Pentazocine on Manic Symptoms |
| Official title | Inpatient Clinical Trial Examining the Effects of Pentazocine on Manic Symptoms |
| Lead sponsor | Mclean Hospital, Other |
| Collaborators | Stanley Medical Research Institute |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Talwin Nx |
| Enrollment | 10 |
| Start date | Sep 1, 2005 |
| Primary completion | Aug 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Aug 2, 2005 |
| Last update posted | Sep 4, 2014 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: